Top Research From SABCS 2025

episode

Breastcancer.org Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Your partner wants profit. You want freedom. Now what? 22 min · 16 Sep 2026 · The Optometry Success Podcast

Board of County Supervisors Meeting - Work Session - Sep 15, 2026 3h 17m · 15 Sep 2026 · Prince William County Board of Supervisors

Finance and Budget Committee - Sep 15, 2026 1h 43m · 15 Sep 2026 · Prince William County Finance and Budget Committee

Sept. 15, 2026 Board of Supervisors Meeting 8h 46m · 15 Sep 2026 · Fairfax County Board of Supervisors

The Art of True Happiness | Dr. Arthur Brooks 2h 49m · 14 Sep 2026 · Huberman Lab

The Chris Wolfe Podcast: The Power of Quality Supplements 48 min · 14 Sep 2026 · EyeCode Media

Report any issue

Source

Recorded12 Dec 2025

Publisherfeeds.megaphone.fm ↗

Handlerec:14581091

Show notes

The 2025 San Antonio Breast Cancer Symposium featured four days filled with new research findings, poster presentations, and educational sessions. Marisa Weiss, MD, founder and chief medical officer of Breastcancer.org, offers her take on the top results. Listen to the episode to hear Dr. Weiss explain: how giredestrant, a new oral SERD for early-stage, hormone receptor-positive breast cancer, may change practice a new use for Tukysa (chemical name: tucatinib) in metastatic HER2-positive disease the lifestyle factors that can affect breast cancer risk and steps people can take to keep their risk as low as possible

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in